MONCTON, N.B. – The provincial government has selected Medavie Blue Cross to administer the New Brunswick Drug Plan, leading to the creation of 75 term and permanent jobs with the company over five years.
“Simply put, Medavie Blue Cross is uniquely positioned to deliver this critical service to those New Brunswickers who are uninsured," said Health Minister Hugh Flemming.
Of the 75 jobs being created, about 30 will administer the plan and support the creation of a research chair position in the coming years. The remaining 45 positions will be added in other Medavie Blue Cross business areas.
The plan was announced on Tuesday, Dec. 10. To be administered by Medavie Blue Cross on behalf of the provincial government, it will cover drugs listed on the New Brunswick Prescription Drug Program formulary. There will be no deductible, and coverage will not be denied because of age, gender or pre-existing medical conditions.
"Tuesday’s announcement was truly a watershed moment for our province – the most important initiative in health care since the introduction of Medicare in the 1960s,” said Flemming. “The plan will give New Brunswickers the peace of mind that comes with having fair and affordable drug insurance when they need it.”
Flemming said the provincial government chose Medavie Blue Cross because of its proven experience and expertise in designing, implementing and administrating drug plans. Medavie Blue Cross also has a proven record of providing bilingual service to New Brunswickers: it administers the New Brunswick Prescription Drug Program and the Seniors Prescription Drug Program.
"Medavie Blue Cross is one of the largest employers in our province and a vital part of the information technology and business community in Greater Moncton," said Government Services Minister Sue Stultz. “I am proud that our department and our strategic procurement division were able to negotiate the contract with Medavie Blue Cross to secure best value for taxpayer dollars on behalf of the department of health and good-paying jobs for the people of New Brunswick.
"Ultimately it was the collaboration between our respective departments and successful negotiations with Medavie Blue Cross that allowed for the value-added creation of net new jobs and a new research position," Stultz added.
“We are pleased to have been selected to administer the New Brunswick Drug Plan,” said Martin Haynes, vice-president government, Medavie Blue Cross. “We have extensive experience administering government programs at both the provincial and federal levels and a longstanding history in this province. Today, about half of our 2,000 employees are based in New Brunswick, including a strong contingent in information technology and professional roles. The addition of new roles to administer this program will add to our local expertise that can be expanded into other markets.”
More information about the New Brunswick Drug Plan is on the Department of Health website.